Actively Recruiting
The Immune Assessment of PD-1 Antibody Therapy in Tumor
Led by Quanli Gao · Updated on 2024-11-18
3000
Participants Needed
1
Research Sites
488 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This retrospective study will leverage previous immune function monitoring results in conjunction with clinical case data at this medical center.
CONDITIONS
Official Title
The Immune Assessment of PD-1 Antibody Therapy in Tumor
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age ≥18 years
- Pathologically confirmed malignant tumors
- Complete medical records
- Assessable immune function test data
You will not qualify if you...
- Age <18 years
- No confirmed tumor pathology
- Untraceable medical records
- Non-assessable immune function tests
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
Zhengzhou, Henan, China, 450008
Actively Recruiting
Research Team
X
Xiaomin Fu
CONTACT
X
Xiaomin Fu
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here